Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade ; day:12 ; month:10 ; year:2018 ; pages:1-12
Cancer immunology immunotherapy ; (12.10.2018), 1-12
- Creator
-
Grauers Wiktorin, Hanna
- Contributor
-
Nilsson, Malin S.
Kiffin, Roberta
Sander, Frida Ewald
Lenox, Brianna
Rydström, Anna
Hellstrand, Kristoffer
Martner, Anna
SpringerLink (Online service)
- DOI
-
10.1007/s00262-018-2253-6
- URN
-
urn:nbn:de:101:1-2018111715464601624542
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grauers Wiktorin, Hanna
- Nilsson, Malin S.
- Kiffin, Roberta
- Sander, Frida Ewald
- Lenox, Brianna
- Rydström, Anna
- Hellstrand, Kristoffer
- Martner, Anna
- SpringerLink (Online service)
Other Objects (12)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Regulatory mechanisms of PD-1/PD-L1 in cancers
The PD-1:PD-L1 axis in Inflammatory Arthritis
PD-1/PD-L1 binding studies using microscale thermophoresis
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC